Qingbo Yang
Qingbo Yang has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Chao Feng
Qilu University of Technology (Shandong Academy of Sciences)
1 shared publication - Dezheng Wang
Rehabilitation Center, Qilu Hospital of Shandong University, Jinan 250012, P. R. China
1 shared publication Dongqing Zuo
1 shared publication- Fangzhou Xu
Qilu University of Technology (Shandong Academy of Sciences)
1 shared publication - Gege Dong
Qilu University of Technology (Shandong Academy of Sciences)
1 shared publication - Hongsheng Wang
Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery, State Key Laboratory of Anti-Infective Drug Discovery and Development, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China
1 shared publication
Latest Publications
- 30 November 2023
- Published by World Scientific Pub Co Pte Ltd in International Journal of Neural Systems
- Vol. 34 (01) , 2350067
Multilevel Laser-Induced Pain Measurement with Wasserstein Generative Adversarial Network — Gradient Penalty Model
Pain is an experience of unpleasant sensations and emotions associated with actual or potential tissue damage. In the global context, billions of people are affected by pain disorders. There are particular challenges in the measurement and assessment of pain, and the commonly used pain measuring tools include traditional subjective scoring methods and biomarker-based measures. The main tools for biomarker-based analysis are electroencephalography (EEG), electrocardiography and functional magnetic resonance. The EEG-based quantitative pain measurements are of immense value in clinical pain management and can provide objective assessments of pain intensity. The assessment of pain is now primarily limited to the identification of the presence or absence of pain, with less research on multilevel pain. High power laser stimulation pain experimental paradigm and five pain level classification methods based on EEG data augmentation are presented. First, the EEG features are extracted using modified S-transform, and the time-frequency information of the features is retained. Based on the pain recognition effect, the 20–40[ ]Hz frequency band features are optimized. Afterwards the Wasserstein generative adversarial network with gradient penalty is used for feature data augmentation. It can be inferred from the good classification performance of features in the parietal region of the brain that the sensory function of the parietal lobe region is effectively activated during the occurrence of pain. By comparing the latest data augmentation methods and classification algorithms, the proposed method has significant advantages for the five-level pain dataset. This research provides new ways of thinking and research methods related to pain recognition, which is essential for the study of neural mechanisms and regulatory mechanisms of pain.
- 30 November 2023
- Published by World Scientific Pub Co Pte Ltd in International Journal of Neural Systems
- Vol. 34 (01) , 2350067
Multilevel Laser-Induced Pain Measurement with Wasserstein Generative Adversarial Network — Gradient Penalty Model
Pain is an experience of unpleasant sensations and emotions associated with actual or potential tissue damage. In the global context, billions of people are affected by pain disorders. There are particular challenges in the measurement and assessment of pain, and the commonly used pain measuring tools include traditional subjective scoring methods and biomarker-based measures. The main tools for biomarker-based analysis are electroencephalography (EEG), electrocardiography and functional magnetic resonance. The EEG-based quantitative pain measurements are of immense value in clinical pain management and can provide objective assessments of pain intensity. The assessment of pain is now primarily limited to the identification of the presence or absence of pain, with less research on multilevel pain. High power laser stimulation pain experimental paradigm and five pain level classification methods based on EEG data augmentation are presented. First, the EEG features are extracted using modified S-transform, and the time-frequency information of the features is retained. Based on the pain recognition effect, the 20–40[ ]Hz frequency band features are optimized. Afterwards the Wasserstein generative adversarial network with gradient penalty is used for feature data augmentation. It can be inferred from the good classification performance of features in the parietal region of the brain that the sensory function of the parietal lobe region is effectively activated during the occurrence of pain. By comparing the latest data augmentation methods and classification algorithms, the proposed method has significant advantages for the five-level pain dataset. This research provides new ways of thinking and research methods related to pain recognition, which is essential for the study of neural mechanisms and regulatory mechanisms of pain.
- 29 March 2023
- Published by Springer Nature
- p. 893-901
Information Aggregation and Fuzzy Decision Making Based on Vague Set Theory
- 29 March 2023
- Published by Springer Nature
- p. 893-901
Information Aggregation and Fuzzy Decision Making Based on Vague Set Theory
- 1 September 2015
- Published by Elsevier in Optics Communications
- Vol. 350, 135-143
Effect of partially coherent laser source on the performance of fiber-coupling DPSK receiver for optical communication
- 1 September 2015
- Published by Elsevier in Optics Communications
- Vol. 350, 135-143
Effect of partially coherent laser source on the performance of fiber-coupling DPSK receiver for optical communication
- 24 September 2014
- Published by Taylor & Francis in Cancer Investigation
- Vol. 32 (10) , 533-542
ErbB Receptors as Prognostic and Therapeutic Drug Targets in Bone and Soft Tissue Sarcomas
ErbB receptors have been intensely studied to understand their importance in cancer biology and as therapeutic targets, and many ErbB inhibitors are now used in the clinical setting. A large number of studies have been conducted to examine the expression of ErbB family members in bone and soft tissue sarcomas, including osteosarcomas, synovial sarcomas, Ewing sarcomas, rhabdomyosarcomas, and so on. Nevertheless, the clinical implications of ErbB receptors remain elusive. To illustrate the potential of ErbB family members as prognostic and therapeutic drug targets in bone and soft tissue sarcomas, we summarized the molecular evidence and observations from clinical and basic trials.
- 24 September 2014
- Published by Taylor & Francis in Cancer Investigation
- Vol. 32 (10) , 533-542
ErbB Receptors as Prognostic and Therapeutic Drug Targets in Bone and Soft Tissue Sarcomas
ErbB receptors have been intensely studied to understand their importance in cancer biology and as therapeutic targets, and many ErbB inhibitors are now used in the clinical setting. A large number of studies have been conducted to examine the expression of ErbB family members in bone and soft tissue sarcomas, including osteosarcomas, synovial sarcomas, Ewing sarcomas, rhabdomyosarcomas, and so on. Nevertheless, the clinical implications of ErbB receptors remain elusive. To illustrate the potential of ErbB family members as prognostic and therapeutic drug targets in bone and soft tissue sarcomas, we summarized the molecular evidence and observations from clinical and basic trials.